| The mechanisms of HBV-induced hepatocellular carcinoma Y Jiang, Q Han, H Zhao, J Zhang Journal of hepatocellular carcinoma, 435-450, 2021 | 114 | 2021 |
| HCC-derived exosomes: critical player and target for cancer immune escape Q Han, H Zhao, Y Jiang, C Yin, J Zhang Cells 8 (6), 558, 2019 | 112 | 2019 |
| TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells A Lin, G Wang, H Zhao, Y Zhang, Q Han, C Zhang, Z Tian, J Zhang Oncoimmunology 5 (2), e1074376, 2016 | 80 | 2016 |
| Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis Y Jiang, Q Han, H Zhao, J Zhang Journal of Experimental & Clinical Cancer Research 40, 1-18, 2021 | 61 | 2021 |
| Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis Y Li, Z Song, Q Han, H Zhao, Z Pan, Z Lei, J Zhang Molecular oncology 16 (15), 2861-2880, 2022 | 35 | 2022 |
| Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity X Wang, R Hu, Z Song, H Zhao, Z Pan, Y Feng, Y Yu, Q Han, J Zhang Cancer Letters 547, 215880, 2022 | 23 | 2022 |
| Poly I: C-based rHBVvac therapeutic vaccine eliminates HBV via generation of HBV-specific CD8+ effector memory T cells HJ Zhao, QJ Han, G Wang, A Lin, DQ Xu, YQ Wang, LH Zhao, ZG Tian, ... Gut 68 (11), 2032-2043, 2019 | 23 | 2019 |
| TLR2 Promotes Monocyte/Macrophage Recruitment Into the Liver and Microabscess Formation to Limit the Spread of Listeria Monocytogenes G Wang, H Zhao, B Zheng, D Li, Y Yuan, Q Han, Z Tian, J Zhang Frontiers in immunology 10, 1388, 2019 | 21 | 2019 |
| An intelligent nanovehicle armed with multifunctional navigation for precise delivery of Toll‐like receptor 7/8 agonist and immunogenic cell death amplifiers to eliminate solid … Y Hao, H Li, H Zhao, Y Liu, X Ge, X Li, H Chen, A Yang, J Zou, X Li, X Sun, ... Advanced healthcare materials 11 (12), 2102739, 2022 | 18 | 2022 |
| Innate and adaptive immune escape mechanisms of hepatitis B virus HJ Zhao, YF Hu, QJ Han, J Zhang World Journal of Gastroenterology 28 (9), 881, 2022 | 18 | 2022 |
| Chitosan nanovaccines as efficient carrier adjuvant system for IL-12 with enhanced protection against HBV H Zhao, H Wang, Y Hu, D Xu, C Yin, Q Han, J Zhang International journal of nanomedicine, 4913-4928, 2021 | 17 | 2021 |
| IFN‐γ protects from apoptotic neutrophil‐mediated tissue injury during acute Listeria monocytogenes infection G Wang, A Lin, Q Han, H Zhao, Z Tian, J Zhang European Journal of Immunology 48 (9), 1470-1480, 2018 | 14 | 2018 |
| In Situ Tumor Vaccination with Calcium‐Linked Degradable Coacervate Nanocomplex Co‐Delivering Photosensitizer and TLR7/8 Agonist to Trigger Effective Anti‐Tumor Immune Responses Y Liu, H Li, H Zhao, Y Hao, S Van Herck, Z Xu, G Wang, X Wang, X Zhang, ... Advanced Healthcare Materials 11 (12), 2102781, 2022 | 13 | 2022 |
| Napabucasin reduces cancer stem cell characteristics in hepatocellular carcinoma Y Li, Q Han, H Zhao, Q Guo, J Zhang Frontiers in pharmacology 11, 597520, 2020 | 13 | 2020 |
| Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells QJ Han, YL Mu, HJ Zhao, RR Zhao, QJ Guo, YH Su, J Zhang World Journal of Gastroenterology 27 (24), 3581, 2021 | 12 | 2021 |
| Single dose HBsAg CS-γ-PGA nanogels induce potent protective immune responses against HBV infection H Wang, Q Han, H Zhao, D Xu, J Zhang European Journal of Pharmaceutics and Biopharmaceutics 124, 82-88, 2018 | 12 | 2018 |
| HBsAg dampened STING associated activation of NK cells in HBeAg-negative CHB patients B Zheng, Y Yu, Z Pan, Y Feng, H Zhao, Q Han, J Zhang International Journal of Molecular Sciences 22 (14), 7643, 2021 | 11 | 2021 |
| Cholesterol accumulation on dendritic cells reverses chronic hepatitis B virus infection-induced dysfunction H Zhao, Y Yu, Y Wang, L Zhao, A Yang, Y Hu, Z Pan, Z Wang, J Yang, ... Cellular & Molecular Immunology 19 (12), 1347-1360, 2022 | 9 | 2022 |
| CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV H Zhao, Q Han, A Yang, Y Wang, G Wang, A Lin, X Wang, C Yin, J Zhang International Journal of Biological Sciences 18 (1), 154, 2022 | 9 | 2022 |
| Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination W Zhao, H Zhao, B Huang, T Zhao, L Wang, J Zhang, Y Yang, X Tang, ... Signal Transduction and Targeted Therapy 7 (1), 210, 2022 | 5 | 2022 |
